Deferasirox for managing iron overload in people with thalassaemia

BACKGROUND: Thalassaemia is a hereditary anaemia due to ineffective erythropoiesis. In particular, people with thalassaemia major develop secondary iron overload resulting from regular red blood cell transfusions. Iron chelation therapy is needed to prevent long‐term complications. Both deferoxamine...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cochrane Database Syst Rev
Autores principales: Bollig, Claudia, Schell, Lisa K, Rücker, Gerta, Allert, Roman, Motschall, Edith, Niemeyer, Charlotte M, Bassler, Dirk, Meerpohl, Joerg J
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley & Sons, Ltd 2017
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6483623/
https://ncbi.nlm.nih.gov/pubmed/28809446
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007476.pub3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares